Wound Treatments in Brazil

Publication Date	May 2009
Publisher	Euromonitor
Product Type	Report
Pages	43
ISBN Number	not applicable
Product Code	EUR00292

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Wound Treatments in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

sticking plasters, other wound treatments

Data coverage:

market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the wound treatments industry
Identify growth sectors and factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Wound Treatments in Brazil
Euromonitor International
May 2009
List of Contents and Tables
- Executive Summary
- Positive Economy Indicators Push Sales of OTC Healthcare
- New Rules for OTC Advertising
- Hypermarcas Acquires Dm Ind??stria Farmac??utica and Farmasa
- Further Consolidation of Drugstores
- Slowdown Growth in the Next Two Years
- Key Trends and Developments
- Further Restriction To Advertising of OTC Products
- Hypermarcas Acquires Two Leading OTC Manufacturers
- Specific Department for OTC Products Established Within Anvisa
- Financial Crisis Affects OTC Products
- Senior Consumers and Women Over 40 Years Old Attract Investment
- Market Indicators
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Market Data
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
- OTC Registration and Classification
- De-reimbursement
- Advertising
- Packaging and Labelling
- Distribution
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication and Preventative Medicine
- Generics
- Switches
Summary 1 OTC Healthcare Switches 2005-2007
- Definitions
Summary 2 Research Sources
- Ach?(C) Laborat??rios Farmac??uticos SA
- Strategic Direction
- Key Facts
Summary 3 Ach?(C) Laborat??rios Farmac??uticos SA: Key Facts
Summary 4 Ach?(C) Laborat??rios Farmac??uticos SA: Operational Indicators
- Company Background
- Production
Summary 5 Ach?(C) Laborat??rios Farmac??uticos SA: Production Statistics 2007
- Competitive Positioning
Summary 6 Ach?(C) Laborat??rios Farmac??uticos SA: Competitive Position 2008
- Bayer SA
- Strategic Direction
- Key Facts
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 9 Bayer SA: Competitive Position 2008
- Boehringer Ingelheim Do Brasil Qu?-mica E Farmac??utica Ltda
- Strategic Direction
- Key Facts
Summary 10 Boehringer Ingelheim do Brasil Qu?-mica e Farmac??utica Ltda: Key Facts
Summary 11 Boehringer Ingelheim do Brasil Qu?-mica e Farmac??utica Ltda: Operational Indicators
- Company Background
- Production
Summary 12 Boehringer Ingelheim do Brasil Qu?-mica e Farmac??utica Ltda: Production Statistics 2007
- Competitive Positioning
Summary 13 Boehringer Ingelheim do Brasil Qu?-mica e Farmac??utica Ltda: Competitive Position 2008
- Dm Ind??stria Farmac??utica Ltda
- Strategic Direction
- Key Facts
Summary 14 DM Ind??stria Farmac??utica Ltda: Key Facts
Summary 15 DM Ind??stria Farmac??utica Ltda: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 16 DM Ind??stria Farmac??utica Ltda: Competitive Position 2008
- Ems SA
- Strategic Direction
- Key Facts
Summary 17 EMS SA: Key Facts
Summary 18 EMS SA: Operational Indicators
- Company Background
- Production
Summary 19 EMS SA: Production Statistics 2007
- Competitive Positioning
Summary 20 EMS SA: Competitive Position 2008
- Eurofarma Laborat??rio Ltda
- Strategic Direction
- Key Facts
Summary 21 Eurofarma Laborat??rio Ltda: Key Facts
Summary 22 Eurofarma Laborat??rio Ltda: Operational Indicators
- Company Background
- Production
Summary 23 Eurofarma Laborat??rio Ltda: Production Statistics 2007
- Competitive Positioning
Summary 24 Eurofarma Laborat??rio Ltda: Competitive Position 2008
- Janssen-cilag Farmaceutica Ltda
- Strategic Direction
- Key Facts
Summary 25 Janssen-Cilag Farmac??utica Ltda: Key Facts
- Company Background
- Production
- Competitive Positioning
Summary 26 Janssen-Cilag Farmac??utica Ltda: Competitive Position 2008
- Medley SA Ind??stria Farmac??utica
- Strategic Direction
- Key Facts
Summary 27 Medley SA Ind??stria Farmac??utica: Key Facts
Summary 28 Medley SA Ind??stria Farmac??utica: Operational Indicators
- Company Background
- Production
Summary 29 Medley SA Ind??stria Farmac??utica: Production Statistics 2007
- Competitive Positioning
Summary 30 Medley SA Ind??stria Farmac??utica: Competitive Position 2008
- Nycomed Pharma Ltda
- Strategic Direction
- Key Facts
Summary 31 Nycomed Pharma Ltda: Key Facts
Summary 32 Nycomed Pharma Ltda: Operational Indicators
- Company Background
- Production
Summary 33 Nycomed Pharma Ltda: Production Statistics 2007
- Competitive Positioning
Summary 34 Nycomed Pharma Ltda: Competitive Position 2008
- Sanofi-aventis Farmac??utica Ltda
- Strategic Direction
- Key Facts
Summary 35 Sanofi-Aventis Farmac??utica Ltda: Key Facts
Summary 36 Sanofi-Aventis Farmac??utica Ltda: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 37 Sanofi-Aventis Farmac??utica Ltda: Competitive Position 2008
- Headlines
- Sector Data
- Table 11 Sales of Wound Treatments by Subsector: Value 2003-2008
- Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
- Table 13 Wound Treatments Company Shares by Value 2004-2008
- Table 14 Wound Treatments Brand Shares by Value 2005-2008
- Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
- Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013